{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T20:05:04Z","timestamp":1792267504702,"version":"4.4.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.yrtph.2026.106194","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T06:35:35Z","timestamp":1785220535000},"page":"106194","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Unique nonclinical safety profile of PF-06835919, a ketohexokinase inhibitor, highlights a species-dependent mechanism"],"prefix":"10.1016","volume":"172","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9239-1624","authenticated-orcid":false,"given":"Jun","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Houle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank J.","family":"Geoly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah N.","family":"Campion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.yrtph.2026.106194_bib1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1017\/S0029665115002451","article-title":"Dietary carbohydrate and control of hepatic gene expression: mechanistic links from ATP and phosphate ester homeostasis to the carbohydrate-response element-binding protein","volume":"75","author":"Agius","year":"2016","journal-title":"Proc. Nutr. Soc."},{"key":"10.1016\/j.yrtph.2026.106194_bib2","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/978687","article-title":"Idealized PPARgamma-based therapies: lessons from bench and bedside","author":"Amato","year":"2012","journal-title":"PPAR Res."},{"key":"10.1016\/j.yrtph.2026.106194_bib3","unstructured":"AVANDIA\u00ae. (Rosiglitazone Maleate) Tablets [Prescribing Information]. GlaxoSmithKline. Research Triangle Park, NC. August 2007. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2007\/021071s027lbl.pdf."},{"key":"10.1016\/j.yrtph.2026.106194_bib4","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.clnesp.2025.06.042","article-title":"The metabolic and molecular mechanisms linking fructose consumption to lipogenesis and metabolic disorders","volume":"69","author":"Baharuddin","year":"2025","journal-title":"Clin Nutr ESPEN"},{"issue":"4","key":"10.1016\/j.yrtph.2026.106194_bib5","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.cell.2006.06.049","article-title":"Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network","volume":"126","author":"Bookout","year":"2006","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.yrtph.2026.106194_bib6","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1517\/14740338.2013.741585","article-title":"Examining the safety of PPAR agonists - current trends and future prospects","volume":"12","author":"Bortolini","year":"2013","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.yrtph.2026.106194_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.reprotox.2026.109294","article-title":"Thyroid dysregulation underlies altered ovarian cyclicity in rats exposed to PF-06835919, a KHK inhibitor","author":"Campion","year":"2026","journal-title":"Reprod. Toxicol."},{"issue":"8","key":"10.1016\/j.yrtph.2026.106194_bib8","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1177\/0192623313478692","article-title":"Spontaneous cardiomyopathy in young Sprague-Dawley rats: evaluation of biological and environmental variability","volume":"41","author":"Chanut","year":"2013","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.yrtph.2026.106194_bib9","series-title":"Ultrastructural Pathology: the Comparative Cellular Basis of Disease","first-page":"153","article-title":"Peroxisomes, smooth endoplasmic reticulum, and lipids","author":"Cheville","year":"2009"},{"issue":"1","key":"10.1016\/j.yrtph.2026.106194_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10408444.2013.835784","article-title":"Mode of action framework analysis for receptor-mediated toxicity: the peroxisome proliferator-activated receptor alpha (PPARalpha) as a case study","volume":"44","author":"Corton","year":"2014","journal-title":"Crit. Rev. Toxicol."},{"issue":"1","key":"10.1016\/j.yrtph.2026.106194_bib11","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1080\/019262301301418865","article-title":"Pathogenesis of male reproductive toxicity","volume":"29","author":"Creasy","year":"2001","journal-title":"Toxicol. Pathol."},{"issue":"1","key":"10.1016\/j.yrtph.2026.106194_bib12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0008-6363(98)00076-5","article-title":"Rat models of hypertension, cardiac hypertrophy and failure","volume":"39","author":"Doggrell","year":"1998","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.yrtph.2026.106194_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yrtph.2017.11.003","article-title":"Human relevance of rodent liver tumors: key insights from a Toxicology Forum workshop on nongenotoxic modes of action","volume":"92","author":"Felter","year":"2018","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"22","key":"10.1016\/j.yrtph.2026.106194_bib14","doi-asserted-by":"crossref","first-page":"13546","DOI":"10.1021\/acs.jmedchem.0c00944","article-title":"Discovery of PF-06835919: a potent inhibitor of ketohexokinase (KHK) for the treatment of metabolic disorders driven by the overconsumption of fructose","volume":"63","author":"Futatsugi","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.yrtph.2026.106194_bib15","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3389\/fendo.2014.00188","article-title":"Thyroid hormone function in the rat testis","volume":"5","author":"Gao","year":"2014","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.yrtph.2026.106194_bib16","series-title":"Histopathology of Preclinical Toxicity Studies","first-page":"457","article-title":"Liver and pancreas","author":"Greaves","year":"2007"},{"key":"10.1016\/j.yrtph.2026.106194_bib17","series-title":"Histopathology of Preclinical Studies: Interpretation and Relevance in Drug Safety Evaluation","first-page":"772","article-title":"Endocrine glands","author":"Greaves","year":"2012"},{"issue":"4","key":"10.1016\/j.yrtph.2026.106194_bib18","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/S0026-895X(24)12334-6","article-title":"Induction of rat organic anion transporting polypeptide 2 by pregnenolone-16alpha-carbonitrile is via interaction with pregnane X receptor","volume":"61","author":"Guo","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.yrtph.2026.106194_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101196","article-title":"Pharmacologic inhibition of ketohexokinase prevents fructose-induced metabolic dysfunction","volume":"48","author":"Gutierrez","year":"2021","journal-title":"Mol Metab"},{"issue":"2","key":"10.1016\/j.yrtph.2026.106194_bib20","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1093\/toxsci\/kfl116","article-title":"Identification of genes controlled by the pregnane X receptor by microarray analysis of mRNAs from pregnenolone 16alpha-carbonitrile-treated rats","volume":"94","author":"Guzelian","year":"2006","journal-title":"Toxicol. Sci."},{"issue":"10","key":"10.1016\/j.yrtph.2026.106194_bib21","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.tem.2016.06.005","article-title":"The sweet path to Metabolic demise: fructose and lipid synthesis","volume":"27","author":"Herman","year":"2016","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.yrtph.2026.106194_bib22","series-title":"Guidance on Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals","year":"2009"},{"key":"10.1016\/j.yrtph.2026.106194_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodres.2025.117009","article-title":"The evolutionary relationship between sugar-sweetened beverages and type 2 diabetes mellitus since 1989","volume":"219","author":"Jian","year":"2025","journal-title":"Food Res. Int."},{"issue":"1","key":"10.1016\/j.yrtph.2026.106194_bib24","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1210\/er.2008-0033","article-title":"Hypothesis: could excessive fructose intake and uric acid cause type 2 diabetes?","volume":"30","author":"Johnson","year":"2009","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.yrtph.2026.106194_bib25","first-page":"37","article-title":"Fructosuria in a Sudanese family","volume":"3","author":"Karrar","year":"1984","journal-title":"Sudanese Journal of Paediatrics"},{"issue":"7","key":"10.1016\/j.yrtph.2026.106194_bib26","first-page":"800","article-title":"Inhibition of ketohexokinase in adults with NAFLD reduces liver fat and inflammatory markers: a randomized phase 2 trial","volume":"2","author":"Kazierad","year":"2021","journal-title":"M\u00e9d. Sur"},{"issue":"2","key":"10.1016\/j.yrtph.2026.106194_bib27","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/toxsci\/kfn007","article-title":"Persistent induction of hepatic and pulmonary phase II enzymes by 3-methylcholanthrene in rats","volume":"102","author":"Kondraganti","year":"2008","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2026.106194_bib28","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.2147\/DMSO.S216791","article-title":"How Western diet and lifestyle drive the pandemic of obesity and civilization diseases","volume":"12","author":"Kopp","year":"2019","journal-title":"Diabetes Metab. Syndr. Obes."},{"issue":"7","key":"10.1016\/j.yrtph.2026.106194_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17070999","article-title":"Pleiotropic actions of Peroxisome proliferator-activated receptors (PPARs) in dysregulated metabolic homeostasis, inflammation and cancer: current evidence and future perspectives","volume":"17","author":"Lagana","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yrtph.2026.106194_bib30","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1038\/ncomms3434","article-title":"Endogenous fructose production and metabolism in the liver contributes to the development of metabolic syndrome","volume":"4","author":"Lanaspa","year":"2013","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.yrtph.2026.106194_bib31","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1741-4520.2011.00314.x","article-title":"Hypothyroidism caused by phenobarbital affects patterns of estrous cyclicity in rats","volume":"51","author":"Li","year":"2011","journal-title":"Congenital. Anom."},{"issue":"1","key":"10.1016\/j.yrtph.2026.106194_bib32","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13048-017-0314-7","article-title":"Prolonged hypothyroidism severely reduces ovarian follicular reserve in adult rats","volume":"10","author":"Meng","year":"2017","journal-title":"J. Ovarian Res."},{"issue":"5","key":"10.1016\/j.yrtph.2026.106194_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4236\/ojemd.2013.35A001","article-title":"PPAR and local renin-angiotensin systems in cardiovascular and metabolic diseases associated with obesity: a unifying Hypothesis","volume":"3","author":"M\u00e1rquez-Salom","year":"2013","journal-title":"Open J. Endocr. Metab. Dis."},{"issue":"3","key":"10.1016\/j.yrtph.2026.106194_bib34","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/BF01858115","article-title":"Ventricular performance in spontaneously hypertensive rats (SHR) with reduced cardiac mass","volume":"3","author":"Natsume","year":"1989","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.yrtph.2026.106194_bib37","series-title":"Test No. 452: Chronic Toxicity Studies. Organisation for Economic Co-operation and Development (OECD) Guidelines for the Testing of Chemicals, Section 4","year":"2018"},{"issue":"6","key":"10.1016\/j.yrtph.2026.106194_bib39","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0024-3205(90)90081-2","article-title":"Activity of the hypothalamo-pituitary ovarian axis in hypothyroid rats with or without triiodothyronine replacement","volume":"46","author":"Ortega","year":"1990","journal-title":"Life Sci."},{"key":"10.1016\/j.yrtph.2026.106194_bib40","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.toxrep.2020.12.019","article-title":"Species differences in phenobarbital-mediated UGT gene induction in rat and human liver microtissues","volume":"8","author":"Plummer","year":"2021","journal-title":"Toxicol. Rep."},{"issue":"1","key":"10.1016\/j.yrtph.2026.106194_bib41","doi-asserted-by":"crossref","DOI":"10.1111\/cts.13644","article-title":"Study of the ketohexokinase inhibitor PF-06835919 as a clinical cytochrome P450 3A inducer: integrated use of oral midazolam and liquid biopsy","volume":"17","author":"Qiu","year":"2024","journal-title":"Clin. Transl. Sci."},{"issue":"8","key":"10.1016\/j.yrtph.2026.106194_bib42","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.bbalip.2007.02.003","article-title":"Safety issues and prospects for future generations of PPAR modulators","volume":"1771","author":"Rubenstrunk","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"issue":"4","key":"10.1016\/j.yrtph.2026.106194_bib43","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1111\/dom.14946","article-title":"A phase 2a, randomized, double-blind, placebo-controlled, three-arm, parallel-group study to assess the efficacy, safety, tolerability and pharmacodynamics of PF-06835919 in patients with non-alcoholic fatty liver disease and type 2 diabetes","volume":"25","author":"Saxena","year":"2023","journal-title":"Diabetes Obes. Metabol."},{"issue":"2","key":"10.1016\/j.yrtph.2026.106194_bib44","article-title":"Ketohexokinase inhibition improves NASH by reducing fructose-induced steatosis and fibrogenesis","volume":"3","author":"Shepherd","year":"2021","journal-title":"JHEP Rep."},{"issue":"5","key":"10.1016\/j.yrtph.2026.106194_bib45","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1161\/01.HYP.11.5.416","article-title":"Effects of moderate hypertension on cardiac function and metabolism in the rabbit","volume":"11","author":"Taegtmeyer","year":"1988","journal-title":"Hypertension"},{"issue":"7 Suppl. l","key":"10.1016\/j.yrtph.2026.106194_bib46","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1177\/0192623310386499","article-title":"Proliferative and nonproliferative lesions of the rat and mouse hepatobiliary system","volume":"38","author":"Thoolen","year":"2010","journal-title":"Toxicol. Pathol."},{"issue":"4","key":"10.1016\/j.yrtph.2026.106194_bib47","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1124\/dmd.121.000498","article-title":"Mechanisms by which inducers of drug metabolizing enzymes alter Thyroid Hormones in rats","volume":"50","author":"Vansell","year":"2022","journal-title":"Drug Metabol. Dispos."},{"issue":"3","key":"10.1016\/j.yrtph.2026.106194_bib48","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1677\/JOE-08-0218","article-title":"The role of thyroid hormone in testicular development and function","volume":"199","author":"Wagner","year":"2008","journal-title":"J. Endocrinol."},{"issue":"1","key":"10.1016\/j.yrtph.2026.106194_bib49","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1093\/toxsci\/kfm193","article-title":"Nonclinical safety evaluation of muraglitazar, a novel PPARalpha\/gamma agonist","volume":"100","author":"Waites","year":"2007","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2026.106194_bib50","series-title":"Endocrine Toxicology","first-page":"51","article-title":"Toxic effects of xenobiotics on the pituitary gland","author":"Walker","year":"1992"},{"issue":"9","key":"10.1016\/j.yrtph.2026.106194_bib51","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1124\/dmd.122.000953","article-title":"Transporter-enzyme interplay in the pharmacokinetics of PF-06835919, a first-in-class ketohexokinase inhibitor for metabolic disorders and nonalcoholic fatty liver disease","volume":"50","author":"Weng","year":"2022","journal-title":"Drug Metab. Dispos."},{"issue":"2","key":"10.1016\/j.yrtph.2026.106194_bib52","doi-asserted-by":"crossref","DOI":"10.3390\/cells9020352","article-title":"PPAR-Mediated toxicology and applied pharmacology","volume":"9","author":"Xi","year":"2020","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.yrtph.2026.106194_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2025.104318","article-title":"Drugs targeting peroxisome proliferator-activated receptors","volume":"30","author":"Xie","year":"2025","journal-title":"Drug Discov. Today"},{"issue":"8","key":"10.1016\/j.yrtph.2026.106194_bib54","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1124\/dmd.30.8.918","article-title":"Role of constitutive androstane receptor in the in vivo induction of Mrp3 and CYP2B1\/2 by phenobarbital","volume":"30","author":"Xiong","year":"2002","journal-title":"Drug Metab. Dispos."},{"issue":"1","key":"10.1016\/j.yrtph.2026.106194_bib55","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2025.2592431","article-title":"Added sugars, gut microbiota, and host health","volume":"17","author":"Zhang","year":"2025","journal-title":"Gut Microbes"}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230026001674?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230026001674?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T11:04:16Z","timestamp":1791457456000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0273230026001674"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":52,"alternative-id":["S0273230026001674"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2026.106194","relation":{},"ISSN":["0273-2300"],"issn-type":[{"value":"0273-2300","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unique nonclinical safety profile of PF-06835919, a ketohexokinase inhibitor, highlights a species-dependent mechanism","name":"articletitle","label":"Article Title"},{"value":"Regulatory Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yrtph.2026.106194","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106194"}}